A total of 30 patient advocacy groups working to further understanding and the needs of people living with rare diseases…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
A large proportion of people with acute intermittent porphyria (AIP) may still be undiagnosed in China, according to a recent…
A report has described for the first time the case of a patient having an acute intermittent porphyria (AIP)…
A high-dose regimen of hydroxychloroquine given over a short period of time can successfully treat porphyria cutanea tarda (PCT), according…
A new mutation in the FECH gene was identified as the cause of erythropoietic protoporphyria in a…
An 18-year-old woman developed skin lesions associated with variegate porphyria (VP) — a type of acute porphyria — after…
Vitamin D supplements can increase the levels of that vitamin in the blood of patients with erythropoietic protoporphyria (EPP),…
A previously identified mutation in the PPOX gene in a Moroccan Jewish population may cause variegate porphyria by impairing…
The Canadian Agency for Drugs and Technology in Health, called CADTH, has recommended that Givlaari (givosiran) be reimbursed by…
Recurrent attacks in people with acute hepatic porphyria (AHP) are associated with lower lifetime earnings and pose a higher…